{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:25:01Z","timestamp":1784373901797,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary pulmonary lymphoepithelioma-like carcinoma (pLELC) is a rare non-small cell lung cancer (NSCLC) subtype. Clinical features have been described in our previous report, but molecular characteristics remain unclear. Herein, pLELC genomic features were explored. Among 41,574 lung cancers, 128 pLELCs and 162 non-pLELC NSCLCs were enrolled. Programmed cell death ligand 1 (PD-L1) and protein 53 (p53) expression was detected in 47 surgically resected pLELC samples by immunohistochemical assays. Multiomics genomic analyses, including whole-genome sequencing (WGS), RNA whole-transcriptome sequencing (RNA-seq), and Epstein-Barr virus (EBV) integration analyses, were performed on eight frozen pLELC tissues and compared with 50 lung adenocarcinomas (LUADs) and 50 lung squamous cell carcinomas (LUSCs) from The Cancer Genome Atlas (TCGA) and another 26 EBV-positive nasopharynx cancers (EBV<jats:sup>+<\/jats:sup>-NPCs). Progression-free survival (PFS) and overall survival (OS) of pLELC patients were better than those of non-pLELC patients. High PD-L1 or p53 expression was associated with extended disease-free survival (DFS). pLELC had 14 frequently mutated genes (FMGs). Somatically mutated genes and enrichment of genetic lesions were found, which differed from observations in LUAD, LUSC, and EBV<jats:sup>+<\/jats:sup>-nasopharyngeal carcinoma (NPC). Three tumor-associated genes, zinc finger and BTB domain-containing 16 (<jats:italic>ZBTB16<\/jats:italic>), peroxisome proliferator activated receptor gamma (<jats:italic>PPARG<\/jats:italic>), and transforming growth factor beta receptor 2 (<jats:italic>TGFBR2<\/jats:italic>), were downregulated with copy number variation (CNV) loss. EBV was prone to integrating into intergenic and intronic regions with two upregulated miR-BamH1-A rightward transcripts (<jats:italic>BART<\/jats:italic>s),<jats:italic>BART5-3P<\/jats:italic>and<jats:italic>BART20-3P<\/jats:italic>. Our findings reveal that pLELC has a distinct genomic signature. Three tumor-associated genes with CNV loss and two miR-<jats:italic>BART<\/jats:italic>s might be involved in pLELC tumorigenesis.<\/jats:p>","DOI":"10.1038\/s41392-020-00382-6","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T23:03:46Z","timestamp":1610060626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses"],"prefix":"10.1038","volume":"6","author":[{"given":"Bojiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"382_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.17235\/reed.2020.6503\/2019","volume":"112","author":"M Chaparro Mirete","year":"2020","unstructured":"Chaparro Mirete, M., Lopez-Lopez, V. & Robles Campos, R. Lymphoepithelioma-like carcinoma of the duodenum: a very infrequent tumor. Rev. Esp. Enferm. Dig. 112, 239 (2020).","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"382_CR2","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.7150\/jca.37282","volume":"11","author":"R Ayee","year":"2020","unstructured":"Ayee, R., Ofori, M. E. O., Wright, E. & Quaye, O. Epstein Barr virus associated lymphomas and epithelia cancers in humans. J. Cancer 11, 1737\u20131750 (2020).","journal-title":"J. Cancer"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D. et al. The 2015 World Health Organization Classification of Lung Tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10, 1243\u20131260 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/j.cllc.2018.12.014","volume":"20","author":"Y Qin","year":"2019","unstructured":"Qin, Y. et al. Clinical features and prognosis of pulmonary lymphoepithelioma-like carcinoma: summary of eighty-five cases. Clin. Lung Cancer 20, e329\u2013e337 (2019).","journal-title":"Clin. Lung Cancer"},{"key":"382_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12931-019-1236-2","volume":"20","author":"B Chen","year":"2019","unstructured":"Chen, B. et al. Primary pulmonary lymphoepithelioma-like carcinoma: a rare type of lung cancer with a favorable outcome in comparison to squamous carcinoma. Respir. Res. 20, 262 (2019).","journal-title":"Respir. Res."},{"key":"382_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-020-1344-3","volume":"37","author":"Y Fan","year":"2020","unstructured":"Fan, Y., Li, C., Qin, J. & Lu, H. Primary pulmonary lymphoepithelioma-like carcinoma. Med. Oncol. 37, 20 (2020).","journal-title":"Med. Oncol."},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"8595","DOI":"10.2147\/OTT.S219512","volume":"12","author":"ZX Qiu","year":"2019","unstructured":"Qiu, Z. X., Zhou, P. & Wang, K. Primary pulmonary lymphoepithelioma-like carcinoma response favorably to nivolumab: a case report. Onco Targets Ther. 12, 8595\u20138600 (2019).","journal-title":"Onco Targets Ther."},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"33019","DOI":"10.18632\/oncotarget.5028","volume":"6","author":"W Fang","year":"2015","unstructured":"Fang, W. et al. PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival. Oncotarget 6, 33019\u201333032 (2015).","journal-title":"Oncotarget"},{"key":"382_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.lungcan.2015.03.017","volume":"88","author":"YL Chang","year":"2015","unstructured":"Chang, Y. L. et al. PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: a potential rationale for immunotherapy. Lung Cancer 88, 254\u2013259 (2015).","journal-title":"Lung Cancer"},{"key":"382_CR10","doi-asserted-by":"crossref","unstructured":"Hopkins, A. C. et al. T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma. JCI Insight 3, e122092 (2018).","DOI":"10.1172\/jci.insight.122092"},{"key":"382_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10902-w","volume":"10","author":"S Hong","year":"2019","unstructured":"Hong, S. et al. The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma. Nat. Commun. 10, 3108 (2019).","journal-title":"Nat. Commun."},{"key":"382_CR12","doi-asserted-by":"crossref","unstructured":"Chau, S. L. et al. Distinct molecular landscape of Epstein-Barr virus associated pulmonary lymphoepithelioma-like carcinoma revealed by genomic sequencing. Cancers 12, 2065 (2020).","DOI":"10.3390\/cancers12082065"},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.7150\/thno.29622","volume":"9","author":"M Xu","year":"2019","unstructured":"Xu, M. et al. Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies. Theranostics 9, 1115\u20131124 (2019).","journal-title":"Theranostics"},{"key":"382_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lungcan.2016.05.001","volume":"97","author":"YJ Cha","year":"2016","unstructured":"Cha, Y. J. et al. Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status. Lung Cancer 97, 73\u201380 (2016).","journal-title":"Lung Cancer"},{"key":"382_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40902-019-0239-8","volume":"41","author":"I Tojyo","year":"2019","unstructured":"Tojyo, I. et al. PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma. Maxillofac. Plast. Reconstr. Surg. 41, 56 (2019).","journal-title":"Maxillofac. Plast. Reconstr. Surg."},{"key":"382_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"D652","DOI":"10.1093\/nar\/gkp995","volume":"38","author":"SA Forbes","year":"2010","unstructured":"Forbes, S. A. et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res. 38, D652\u2013D657 (2010).","journal-title":"Nucleic Acids Res."},{"key":"382_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/ng.3006","volume":"46","author":"DC Lin","year":"2014","unstructured":"Lin, D. C. et al. The genomic landscape of nasopharyngeal carcinoma. Nat. Genet. 46, 866\u2013871 (2014).","journal-title":"Nat. Genet."},{"key":"382_CR19","first-page":"1451","volume":"8","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma. Onco Targets Ther. 8, 1451\u20131457 (2015).","journal-title":"Onco Targets Ther."},{"key":"382_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"382_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511\u2013515 (2010).","journal-title":"Nat. Biotechnol."},{"key":"382_CR22","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.21037\/jtd.2018.03.14","volume":"10","author":"X-Y Yu","year":"2018","unstructured":"Yu, X.-Y. et al. Correlation and prognostic significance of PD-L1 and P53 expression in resected primary pulmonary lymphoepithelioma-like carcinoma. J. Thorac. Dis. 10, 1891\u20131902 (2018).","journal-title":"J. Thorac. Dis."},{"key":"382_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.lungcan.2017.01.011","volume":"106","author":"PA VanderLaan","year":"2017","unstructured":"VanderLaan, P. A. et al. Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: correlation with clinical outcomes. Lung Cancer 106, 17\u201321 (2017).","journal-title":"Lung Cancer"},{"key":"382_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lungcan.2016.11.018","volume":"103","author":"M McGowan","year":"2017","unstructured":"McGowan, M. et al. PIK3CA mutations as prognostic factor in squamous cell lung carcinoma. Lung Cancer 103, 52\u201357 (2017).","journal-title":"Lung Cancer"},{"key":"382_CR25","doi-asserted-by":"crossref","unstructured":"Singh, S. A. et al. PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells. Elife 8, e40364 (2019).","DOI":"10.7554\/eLife.40364"},{"key":"382_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10637-019-00791-7","volume":"38","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Expression of the PTEN\/FOXO3a\/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression. Investig. New Drugs 38, 321\u2013328 (2020).","journal-title":"Investig. New Drugs"},{"key":"382_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1158\/1055-9965.EPI-18-1014","volume":"28","author":"KH Stopsack","year":"2019","unstructured":"Stopsack, K. H. et al. Low expression of the androgen-induced tumor suppressor gene PLZF and lethal prostate cancer. Cancer Epidemiol. Biomark. Prev. 28, 707\u2013714 (2019).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"382_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1073\/pnas.1717125115","volume":"115","author":"B Chen","year":"2018","unstructured":"Chen, B. et al. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA 115, 373\u2013378 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"382_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0107-3","volume":"9","author":"H Shen","year":"2018","unstructured":"Shen, H. et al. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. Cell Death Dis. 9, 71 (2018).","journal-title":"Cell Death Dis."},{"key":"382_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2018.01.018","volume":"649","author":"S Yousefnia","year":"2018","unstructured":"Yousefnia, S. et al. The influence of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) ligands on cancer cell tumorigenicity. Gene 649, 14\u201322 (2018).","journal-title":"Gene"},{"key":"382_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/1574888X10666150728122921","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Expression and function of PPARs in cancer stem cells. Curr. Stem Cell Res. Ther. 11, 226\u2013234 (2016).","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"382_CR32","doi-asserted-by":"publisher","first-page":"117108","DOI":"10.1016\/j.lfs.2019.117108","volume":"241","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Telmisartan inhibits oxalate and calcium oxalate crystal-induced epithelial-mesenchymal transformation via PPAR-\u03b3-AKT\/STAT3\/p38 MAPK-Snail pathway. Life Sci. 241, 117108 (2020).","journal-title":"Life Sci."},{"key":"382_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00147-w","volume":"8","author":"M Korpal","year":"2017","unstructured":"Korpal, M. et al. Evasion of immunosurveillance by genomic alterations of PPAR\u03b3\/RXR\u03b1 in bladder cancer. Nat. Commun. 8, 103 (2017).","journal-title":"Nat. Commun."},{"key":"382_CR34","doi-asserted-by":"crossref","unstructured":"Seoane, J. & Gomis, R. R. TGF-\u03b2 family signaling in tumor suppression and cancer progression. Cold Spring Harb. Perspect. Biol. 9, a022277 (2017).","DOI":"10.1101\/cshperspect.a022277"},{"key":"382_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cyto.2017.02.011","volume":"95","author":"A Kariminik","year":"2017","unstructured":"Kariminik, A. & Kheirkhah, B. Tumor growth factor-\u03b2 is an important factor for immunosuppression and tumorgenesis in Polyoma BK virus infection; a systematic review article. Cytokine 95, 64\u201369 (2017).","journal-title":"Cytokine"},{"key":"382_CR36","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544\u2013548 (2018).","journal-title":"Nature"},{"key":"382_CR37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41379-019-0391-9","volume":"33","author":"Z Xie","year":"2020","unstructured":"Xie, Z. et al. A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung. Mod. Pathol. 33, 626\u2013638 (2020).","journal-title":"Mod. Pathol."},{"key":"382_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.biopha.2017.10.033","volume":"96","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt\/\u03b2-catenin signaling pathway. Biomed. Pharmacother. 96, 877\u2013883 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"382_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jcmm.13354","volume":"22","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma. J. Cell. Mol. Med. 22, 38\u201345 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"382_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/path.5018","volume":"244","author":"RW Lung","year":"2018","unstructured":"Lung, R. W. et al. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. J. Pathol. 244, 394\u2013407 (2018).","journal-title":"J. Pathol."},{"key":"382_CR41","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1074\/jbc.RA118.006853","volume":"294","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer. J. Biol. Chem. 294, 4854\u20134866 (2019).","journal-title":"J. Biol. Chem."},{"key":"382_CR42","doi-asserted-by":"crossref","unstructured":"Yoon, C. J. et al. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3\/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas. Gastric Cancer 23, 780\u2013795 (2020).","DOI":"10.1007\/s10120-020-01059-3"},{"key":"382_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007484","volume":"14","author":"X Lyu","year":"2018","unstructured":"Lyu, X. et al. EBV-miR-BART1-5P activates AMPK\/mTOR\/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma. PLoS Pathog. 14, e1007484 (2018).","journal-title":"PLoS Pathog."},{"key":"382_CR44","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hed.25544","volume":"41","author":"W Gao","year":"2019","unstructured":"Gao, W. et al. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma. Head Neck 41, 780\u2013792 (2019).","journal-title":"Head Neck"},{"key":"382_CR45","doi-asserted-by":"crossref","unstructured":"Zheng, X. et al. Epstein-Barr virus MicroRNA miR-BART5-3p inhibits p53 expression. J. Virol. 92, e01022-18 (2018).","DOI":"10.1128\/JVI.01022-18"},{"key":"382_CR46","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jtho.2017.04.011","volume":"12","author":"K Chansky","year":"2017","unstructured":"Chansky, K. et al. The IASLC Lung Cancer Staging Project: external validation of the revision of the TNM stage groupings in the Eighth Edition of the TNM classification of lung cancer. J. Thorac. Oncol. 12, 1109\u20131121 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"382_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182891","volume":"12","author":"B Chen","year":"2017","unstructured":"Chen, B. et al. Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients. PLoS ONE 12, e0182891 (2017).","journal-title":"PLoS ONE"},{"key":"382_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"JC Soria","year":"2018","unstructured":"Soria, J. C. et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N. Engl. J. Med. 378, 113\u2013125 (2018).","journal-title":"N. Engl. J. Med."},{"key":"382_CR49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.annonc.2020.01.011","volume":"31","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance). Ann. Oncol. 31, 487\u2013494 (2020).","journal-title":"Ann. Oncol."},{"key":"382_CR50","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1101\/gr.134635.111","volume":"22","author":"ND Dees","year":"2012","unstructured":"Dees, N. D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589\u20131598 (2012).","journal-title":"Genome Res."},{"key":"382_CR51","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1743-422X-10-314","volume":"10","author":"HJ Yang","year":"2013","unstructured":"Yang, H. J. et al. Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells. Virol. J. 10, 314 (2013).","journal-title":"Virol. J."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-00382-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-00382-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-00382-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:40:25Z","timestamp":1697521225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-00382-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1038\/s41392-020-00382-6","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"11 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}